Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: Indications, benefits, and risks

World Journal of Surgery

Volumn 31, Issue 5, 2007, Pages 905-915

  Ito, Yasuhiro ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDIASTINUM LYMPH NODE; PAPILLARY CARCINOMA; PROPHYLAXIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURGEON; THYROID CARCINOMA; TREATMENT INDICATION;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA, PAPILLARY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 34248184147     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-006-0722-0     Document Type: Article

References (74)

1. Noguchi S, Noguchi A, Murakami N. Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer 1970;26:1053-1060.
2. Shaha AR, Byers RM, Terz JJ. Thyroid cancer surgical practice guidelines. In: Practice Guidelines for Major Cancer Sites. Arlington Heights, IL: Society of Surgical Oncology, 1997; pp 19-97.
3. Roher HD, Simon D, Goretzki PE. Guidelines in oncologic surgery: malignant thyroid tumors. Langenbecks Arch Surg 1997;114:(Suppl II) 142.
4. Ito Y, Jikuzono T, Higashiyiama T, et al. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 2006;30:1821-1828.
5. Dralle H, Gimm O. Lymphadenektomie beim Schilddrusencarcinom. Chirurg 1996;67:788-806.
6. Martenson H, Terins J. Recurrent laryngeal nerve palsy in thyroid gland surgery related to operations and nerves at risk. Arch Surg 1985;120:475-482.
7. Scheumann GF, Seeliger H, Musholt TF, et al. Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 1996;162:677-684.
8. Sobin LH, Wittekind C (editors). UICC; TNM classification of malignant tumors, 6th ed. New York: Wiley-Liss, 2002.
9. Noguchi S, Murakami N, Yamashita H, et al. Papillary thyroid carcinoma. Modified radical neck dissection improves prognosis. Arch Surg 1998;133:276-280.
10. Kupferman ME, Patterson DM, Mandel SJ, et al. Safety of modified radical neck dissection for differentiated thyroid carcinoma. Laryngoscope 2004;114:403-406.
11. Simon D, Goretzki PE, Witte J, et al. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 1996;20:860-866.
12. Cady B, Sedwick CE, Meissner WA, et al. Risk factor analysis in differentiated thyroid carcinoma. Cancer 1979;43:810-820.
13. Buckwalter JA, Thomas CG. Selection of surgical treatment for well-differentiated thyroid carcinomas. Ann Surg 1972;176:565-578.
14. Ito J, Noguchi S, Murakami N, et al. Factors affecting the prognosis of patients with carcinoma of the thyroid. Surg Gynecol Obstet 1980;150:539-544.
15. Rosen IB, Maitland A. Changing the operative strategy for thyroid cancer by node sampling. Am J Surg 1983;146:504-508.
16. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 1986;61:978-996.
17. DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinomas. J Clin Endocrinol Metab 1990;71:414-424.
18. Coburn MC, Wanebo HJ. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Ann Surg 1992;164:671-676.
19. Orsenigo E, Beretta E, Mari G, et al. Modified neck dissection in the treatment of differentiated thyroid carcinoma. Eur J Surg Oncol 1997;23:286-288.
20. Ducci M, Appetecchia M, Marzetti M. Neck dissection for surgical treatment of lymph node metastasis in papillary thyroid carcinoma. J Exp Clin Cancer Res 1997;16:333-335.
21. Mann B, Buhr HJ. Lymph node dissection in patients with differentiated thyroid carcinoma - who benefits? Langenbecks Arch Surg 1998;383:355-358.
22. Palazzo FF, Gosnell J, Savio TS, et al. Lymphadenectomy for papillary thyroid cancer: changes in practice over four decades. Eur J Surg Oncol 2006;32:340-344.
23. Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794-804.
24. Scheumann GFW, Gimm O, Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559-568.
25. Sellers M, Beenken S, Blankenship A, et al. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg 1992;164:578-581.
26. Ozaki O, Ito K, Kobayashi K, et al. Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid. World J Surg 1988;12:825-829.
27. Heinrich S, Schafer M, Rousson V, et al. Evidence-based treatment of acute pancreatitis. A look at established paradigms. Ann Surg 2006;243:154-168.
28. Noguchi M, Kumaki T, Kaniya T, et al. Bilateral cervical lymph node metastases in well-differentiated thyroid cancer. Arch Surg 1990;125:804-806.
29. Sato N, Oyamatsu M, Koyama Y, et al. Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol 1998;69:151-155.
30. Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma. A study of the EORTIC thyroid cancer cooperative group. Eur J Cancer 1979;15:1033-1041.
31. Cady B, Rossi R. An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 1988;104:947-953.
32. Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-1095.
33. Hay ID, Berqstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic system in a cohort of 1779 patients surgically treated at one institution during 1970 through 1989. Surgery 1993;114:1050-1057.
34. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981;70:511-518.
35. Cunningham MP, Duda RB, Recant W, et al. Survival discriminants for differentiated thyroid cancer. Am J Surg 1990;160:344-347.
36. Bacourt F, Asselain B, Savoie JC, et al. Multivariate study of prognostic factors in differentiated thyroid carcinoma and re-evaluation of the important of age. Br J Surg 1986;73:274-277.
37. Attie JN. Modified neck dissection in treatment of thyroid cancer: a safe procedure. Eur J Cancer Clin Oncol 1988;24:315-324.
38. Grabe SKG, Hay ID. Thyroid cancer nodal metastasis. Surg Oncol Clin North Am 1996;5:43-63.
39. Wanebo HJ, Andrews W, Kaiser DL. Thyroid cancer: some basic considerations. Am J Surg 1981;142:474-479.
40. Cady B. Surgery of thyroid cancer. World J Surg 1981;5:3-14.
41. Franssila KO. Prognosis in thyroid carcinoma. Cancer 1975;36:1138-1146.
42. Lungdren CI, Hall P, Dickman PW, et al. Clinically significant prognostic factors for differentiated thyroid carcinoma. A population-based, nested case-control study. Cancer 2006;106:524-531.
43. Marchesi M, Biffoni M, Biancan F, et al. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma. Eur J Surg 2002;558:(Suppl) 46-50.
44. Machens A, Hinze R, Thomusch O, et al. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002;26:22-28.
45. Yokozawa T, Miyauchi A, Kuma K, et al. Accurate and simple method of diagnosing thyroid nodules by the modified technique of ultrasound-guided fine needle aspiration biopsy. Thyroid 1995;5:141-145.
46. Ito Y, Tomoda C, Uruno T, et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 2005;30:91-99.
47. Ito Y, Tomoda C, Uruno T, et al. Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 2004;28:1115-1121.
48. Machens A, Holzhausen HJ, Dralle H. Skip metastasis in thyroid cancer leaping the central lymph node compartment. Arch Surg 2004;139:43-45.
49. Antonelli A, et al. Role of neck ultrasonography in follow-up of patients operated on for different thyroid cancer. Thyroid 1995;5:25-29.
50. Uruno T, Miyauchi A, Shimizu K, et al. Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg 2005;29:493-495.
51. Ito Y, Uruno R, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003;13:381-388.
52. Ito Y, Miyauchi A. Therapeutic strategies for papillary microcarcinoma of the thyroid. Curr Cancer Ther Rev 2005;1:19-25.
53. Ito Y, Tomoda C, Uruno T, et al. Preoperative ultrasonographic examination for lymph node metastasis is useful when designing lymph node dissection for papillary microcarcinoma. World J Surg 2004;28:498-501.
54. Ito Y, Uruno T, Takamura Y, et al. Papillary microcarcinoma of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination. Oncology 2005;68:87-96.
55. Ito Y, Tomoda C, Uruno T, et al. Ultrasound-detectable and anatomopathologically-detectable node metastasis in the lateral compartment as indicators of worse relapse-free survival in patients with papillary carcinoma. World J Surg 2005;29:917-920.
56. Ito Y, Tomoda C, Uruno T, et al. Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 2006;30:780-786.
57. Ito Y, Miyauchi A. An investigation for appropriate surgical treatment of papillary thyroid carcinoma (in Japanese). Endocrine Surg (in press).
58. Ohshima A, Yamashita H, Noguchi S, et al. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch Surg 2000;135:1194-1198.
59. Uruno T, Miyauchi A, Shimizu K, et al. Prognosis after reoperation for local recurrence of papillary thyroid carcinoma. Surg Today 2004;34:891-895.
60. Harwood J, Clark OH, Dunphy JE. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg 1978;136:107-112.
61. Sisson GA, Edison BD, Bytell DE. Transsternal radical neck dissection. Arch Otolaryngol 1973;101:46-49.
62. Block MA, Miller JM, Horn RC Jr. Significance of mediastinal lymph node metastases in carcinoma of the thyroid. Am J Surg 1972;123:702-705.
63. Sugenoya A, Asanuma K, Shingu K, et al. Clinical evaluation of upper mediastinal dissection for differentiated thyroid carcinoma. Surgery 1993;113:541-544.
64. Mueller-Gaetner H-W, Brzac HT, Rehpenning W. Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer 1991;67:1903-1911.
65. Brennan MD, Bergstaralh EJ, van Heerden JA, et al. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970; initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1991;66:11-22.
66. Shaha AR, Loree TR, Shah JP. Prognostic factors and risk groups analysis in follicular carcinoma of the thyroid. Surgery 1995;118:1131-1138.
67. Chow S-M, Law SC, Mendenhall WM, et al. Follicular thyroid carcinoma; prognostic factors and the role of radioiodine. Cancer 2002;95:488-498.
68. Passler C, Scheuba C, Prager G, et al. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 2004;11:131-139.
69. Basic N, Zgajnar J, Hocevar M, et al. Is patient's age a prognostic factor for follicular thyroid carcinoma in the TNM classification system? Thyroid 2005;15:439-448.
70. Besic N, Auersperg M, Golouh R. Prognostic factors in follicular carcinoma of the thyroid - a multivariate survival analysis. Eur J Surg Oncol 1999;25:599-605.
71. Witte J, Goretzki PE, Dieken J, et al. Importance of lymph node metastasis in follicular thyroid cancer. World J Surg 2002;26:1017-1022.
72. Ito Y, Yoshida H, Nakano K, et al. Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid. Br J Cancer 2002;86:912-916.
73. Ito Y, Miyoshi E, Yoshida H, et al. 14-3-3 sigma possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid. Cancer Lett 2003;200:161-166.
74. Ito Y, Yoshida H, Tomoda C, et al. Caveolin-1 and 14-3-3 sigma expression in follicular variant of thyroid papillary carcinoma. Pathol Res Pract 2005;201:545-549.